Q3 2022 EPS Estimates for OrganiGram Holdings Inc. (TSE:OGI) Raised by Jefferies Financial Group

OrganiGram Holdings Inc. (TSE:OGI – Get Rating) – Analysts at Jefferies Financial Group lifted their Q3 2022 earnings estimates for shares of OrganiGram in a research report issued to clients and investors on Wednesday, April 13th. Jefferies Financial Group analyst O. Bennett now anticipates that the company will post earnings of ($0.02) per share for the quarter, up from their previous estimate of ($0.03). Jefferies Financial Group also issued estimates for OrganiGram’s Q4 2022 earnings at ($0.02) EPS, FY2022 earnings at ($0.09) EPS and FY2023 earnings at ($0.04) EPS.

OrganiGram (TSE:OGI – Get Rating) last released its earnings results on Tuesday, April 12th. The company reported C($0.03) earnings per share for the quarter, meeting the consensus estimate of C($0.03). The firm had revenue of C$31.84 million during the quarter, compared to the consensus estimate of C$30.58 million.

Other equities analysts have also recently issued reports about the stock. ATB Capital raised shares of OrganiGram from a “sector perform” rating to an “outperform” rating and set a C$3.00 price objective for the company in a research report on Wednesday. Raymond James set a C$3.00 price objective on shares of OrganiGram and gave the stock an “overweight” rating in a research report on Thursday. Atb Cap Markets raised shares of OrganiGram from a “sector perform” rating to an “outperform” rating in a research report on Tuesday. Alliance Global Partners reduced their price objective on shares of OrganiGram from C$4.00 to C$2.25 and set an “underperform” rating for the company in a research report on Friday, January 7th. Finally, Canaccord Genuity Group raised shares of OrganiGram from a “hold” rating to a “speculative buy” rating and lifted their price objective for the stock from C$3.00 to C$3.25 in a research report on Wednesday, January 12th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of C$3.05.

TSE:OGI opened at C$2.19 on Friday. OrganiGram has a 1-year low of C$1.65 and a 1-year high of C$4.26. The company has a current ratio of 8.40, a quick ratio of 6.60 and a debt-to-equity ratio of 1.67. The firm has a fifty day simple moving average of C$1.96 and a 200 day simple moving average of C$2.32. The stock has a market capitalization of C$686.98 million and a PE ratio of -6.29.

About OrganiGram (Get Rating)

Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.

Further Reading